Rare diseases
Investigational molecules
Locations
Back to France1 204 clinical trials in Lyon, France across 7 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in FranceEssaisCliniques.fr(opens in a new tab)Study of Ritlecitinib Combined with Narrow Band UVB Light Therapy Compared to Ritlecitinib Alone in Adults with Vitiligo
FranceStudy of dupilumab injections to reduce airway inflammation in adults aged 40-85 with chronic obstructive pulmonary disease
FranceEvaluating intravenous lidocaine with intrathecal morphine for pain control in patients undergoing major abdominal surgery through laparotomy
FranceStudy evaluating HER2DX-guided treatment in patients with early-stage HER2-positive breast cancer using trastuzumab, pertuzumab and combination chemotherapy
FranceStudy of ivonescimab with chemotherapy combination for first and second-line treatment in patients with advanced or metastatic gastric and gastroesophageal cancer
FranceStudy of patritumab deruxtecan versus drug combination in patients with hormone receptor-positive, HER2-negative advanced or metastatic breast cancer
FranceStudy of immunosuppression reduction in kidney transplant patients with septic shock or respiratory failure receiving drug combination therapy in intensive care
FranceStudy of Rilvegostomig with Bevacizumab and Tremelimumab as First-line Treatment for Patients with Advanced Liver Cancer
FranceStudy comparing RMC-6236 and docetaxel in previously treated patients with advanced or metastatic non-small cell lung cancer who have RAS mutations
FranceComparing rifampin-free treatment versus rifampin in adults with staphylococcal prosthetic valve endocarditis
FranceStudy of trastuzumab deruxtecan with bevacizumab versus bevacizumab alone as first-line maintenance treatment for patients with HER2-expressing ovarian cancer
FranceStudy of Port Delivery System with ranibizumab given every 36 weeks in patients with neovascular age-related macular degeneration
FranceThe busiest research cities in the country
What the registry says about research in the country
Innovative clinical trials focusing on advanced cancer treatments, including studies for endometrial carcinoma, bladder cancer, and various solid tumors. Current research explores combination therapies with novel immunotherapy approaches.
Multiple studies are evaluating targeted therapies and immunological approaches for various tumor types.
Groundbreaking research in immune system modulation and infectious disease prevention, including studies on COVID-19 vaccines and immune response in critical conditions.
Focus on developing innovative vaccination strategies and immune system interventions.
Studies addressing long-term health conditions, with particular emphasis on kidney disease, cardiovascular health, and metabolic disorders.
Innovative approaches combining established and experimental treatments for improved patient outcomes.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
